Issued alternative "Viagra"

The U.S. government approved the sale of new drugs early, which is expected to end the monopoly of "Viagra" in the market to combat male impotency.

The first competitor very profitable "Viagra" on the market called Levitra and is a German pharmaceutical company Bayer AG. The proliferation of new drugs is a British company GlaxoSmithKline (GSK).

Levitra is an alternative drug for the treatment of internal impotency. Unlike blue pill Viagra, Levitra painted in orange.

In 1998, the German company Pfizer began production of the drug Viagra. During this time, sales of the drug rose to 2 billion dollars a year.

Both products operate on the same principle. Doctors warned that the two drugs can have serious side effects, especially for men with heart disease.

Also this year, the United States market should have a third means of impotency Cialis.

Administration to monitor the food and medicines approved a new drug, based on the results of studies that have shown that men taking the pill Levitra, five times more likely to achieve suitable for sex abuser than those who had a placebo.

Scientists have also conducted studies of several thousand men, showed that Viagra helped more than 70% of them improved erection.

Adverse actions

Office to monitor food and drugs to the attention of scientists and about side effects in men with heart disease.

Management decided that the pill Levitra should not take people recently from heart attack or stroke, and people with too low or too high blood pressure.

The remaining men Levitra may cause side effects as headache, the temperature increase laid nose and sometimes dizziness.

"We know, thanks to a major market research that the market is ready for new options," said head of strategic management department at GSK responsible for drugs from cardiovascular disease, problems in the digestive tract and urology.

According to GSK, Levitra will appear in retail sales in the month of September.